Post Image

Leading the Shift to Proactive Care: The Christ Hospital’s High‑Risk Program Strategy

  • Sarah Campian, MS, CGC
  • April 16, 2026

In the traditional healthcare model, cancer care is often reactive—a race against time that begins only after a diagnosis. But at The Christ Hospital Health Network, the goal is to flip that script. Under the leadership of Dr. Kevin Banks, Executive Director of Precision Health and Pharmacogenomics, the network is turning their focus to identifying …

Read More
Post Image

The Power of Progress: Philip's NF1 Clinical Trial Experience

  • Meagan Farmer
  • May 22, 2024

We had the opportunity to connect with Renie and Philip Moss ahead of Neurofibromatosis Awareness Month. Philip has neurofibromatosis type 1 (NF1). It is associated with many features but most often causes growths called neurofibromas (usually benign) as well as characteristic skin and eye findings.1 Malignant or cancerous tumors are rare.1 You …

Read More